| LKB1 regulates PRMT5 activity in breast cancer H Lattouf, L Kassem, J Jacquemetton, A Choucair, C Poulard, O Trédan, ... International journal of cancer 144 (3), 595-606, 2019 | 52 | 2019 |
| TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients L Kassem, M Deygas, L Fattet, J Lopez, T Goulvent, E Lavergne, ... BMC cancer 15, 1-13, 2015 | 46 | 2015 |
| Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review L Kassem, KS Shohdy, S Lasheen, O Abdel-Rahman, A Ali, ... Critical Reviews in Oncology/Hematology 134, 56-64, 2019 | 40 | 2019 |
| Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis L Kassem, KS Shohdy, S Lasheen, O Abdel-Rahman, T Bachelot Breast cancer 25, 17-27, 2018 | 39 | 2018 |
| Personalized treatment in metastatic triple‐negative breast cancer: The outlook in 2020 HA Azim, M Ghosn, K Oualla, L Kassem The breast journal 26 (1), 69-80, 2020 | 37 | 2020 |
| Analysis of PI3K/mTOR pathway biomarkers and their prognostic value in women with hormone receptor–positive, HER2-negative early breast cancer HA Azim, L Kassem, I Treilleux, Q Wang, MA El Enein, SE Anis, ... Translational oncology 9 (2), 114-123, 2016 | 37 | 2016 |
| Breast cancer targeting through inhibition of the endoplasmic reticulum-based apoptosis regulator Nrh/BCL2L10 A Nougarede, N Popgeorgiev, L Kassem, S Omarjee, S Borel, I Mikaelian, ... Cancer Research 78 (6), 1404-1417, 2018 | 36 | 2018 |
| The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer A Choucair, TH Pham, S Omarjee, J Jacquemetton, L Kassem, O Trédan, ... Oncogene 38 (21), 4015-4027, 2019 | 33 | 2019 |
| Gastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysis KS Shohdy, S Lasheen, L Kassem, O Abdel-Rahman Therapeutic Advances in Drug Safety 8 (11), 337-347, 2017 | 32 | 2017 |
| Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis S Lasheen, KS Shohdy, L Kassem, O Abdel-Rahman Expert Review of Anticancer Therapy 17 (9), 851-856, 2017 | 32 | 2017 |
| Predicting brain metastasis in breast cancer patients: stage versus biology HA Azim, R Abdel-Malek, L Kassem Clinical Breast Cancer 18 (2), e187-e195, 2018 | 28 | 2018 |
| Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network … L Kassem, KS Shohdy, O Abdel-Rahman Current Medical Research and Opinion 34 (5), 903-910, 2018 | 25 | 2018 |
| Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data L Kassem, O Abdel-Rahman Critical Reviews in Oncology/Hematology 108, 1-12, 2016 | 21 | 2016 |
| ERα-36 regulates progesterone receptor activity in breast cancer HP Konan, L Kassem, S Omarjee, A Surmieliova-Garnès, J Jacquemetton, ... Breast Cancer Research 22, 1-16, 2020 | 17 | 2020 |
| Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a phase II trial (ESLC01 study) HA Azim, A Omar, H Atef, H Zawahry, MK Shaker, AHK Abdelmaksoud, ... Journal of hepatocellular carcinoma, 109-119, 2018 | 17 | 2018 |
| Immunotherapeutic approaches in triple-negative breast cancer: state of the art and future perspectives K Oualla, L Kassem, L Nouiakh, L Amaadour, Z Benbrahim, S Arifi, ... International journal of breast cancer 2020, 2020 | 15 | 2020 |
| Clinicopathologic Features of Breast Cancer in Egypt—Contemporary Profile and Future Needs: A Systematic Review and Meta-Analysis HA Azim, H Elghazawy, RM Ghazy, AH Abdelaziz, M Abdelsalam, ... JCO Global Oncology 9, e2200387, 2023 | 13 | 2023 |
| Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes R Teinturier, R Abou Ziki, L Kassem, Y Luo, L Malbeteau, S Gherardi, ... Breast Cancer Research and Treatment 190, 389-401, 2021 | 10 | 2021 |
| Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and … J Jacquemetton, L Kassem, C Poulard, A Dahmani, L De Plater, ... Breast Cancer Research 23 (1), 57, 2021 | 10 | 2021 |
| How to become a breast cancer specialist in 2018: The point of view of the second cohort of the Certificate of Competence in Breast Cancer (CCB2) G Montagna, D Anderson, J Bochenek-Cibor, I Bozovic-Spasojevic, ... The Breast 43, 18-21, 2019 | 10 | 2019 |
